Related Experiment Videos
Available and future treatments for erectile dysfunction.
1Royal Victoria Hospital, Belfast, UK.
Clinical Cornerstone
|September 15, 2005
Summary
Effective treatments for erectile dysfunction (ED) now include oral medications like phosphodiesterase-5 (PDE5) inhibitors, offering a minimally invasive first-line option. Other therapies exist for non-responders, expanding ED management beyond older methods.
Area of Science:
- Urology
- Pharmacology
Background:
- Erectile dysfunction (ED) management has evolved significantly from limited options like psychosexual counseling and surgical implants.
- Minimally invasive oral treatments are now the preferred first-line approach for most patients.
Purpose of the Study:
- To review the current landscape of erectile dysfunction treatments.
- To compare the efficacy and tolerability of various ED therapeutic options.
Main Methods:
- Review of existing literature on pharmacological and non-pharmacological treatments for ED.
- Analysis of clinical trial data for oral agents (PDE5 inhibitors, apomorphine), intracavernosal injections, and other therapies.
Main Results:
- Phosphodiesterase-5 (PDE5) inhibitors (sildenafil, tadalafil, vardenafil) are effective and well-tolerated first-line treatments.
- Apomorphine is effective but may cause nausea; yohimbine shows limited efficacy.
- Intracavernosal injections and other methods like testosterone and vacuum pumps are options for non-responders.
Conclusions:
- A diverse range of effective treatments for erectile dysfunction is available, with oral PDE5 inhibitors as the primary choice.
- Treatment selection should be individualized based on patient response, tolerability, and underlying causes of ED.